SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001104659-17-020859
Filing Date
2017-04-03
Accepted
2017-04-03 09:00:35
Documents
6
Effectiveness Date
2017-04-03

Document Format Files

Seq Description Document Type Size
1 DEFA14A a17-10313_2defa14a.htm DEFA14A 63455
2 GRAPHIC g103132bci001.jpg GRAPHIC 2107
3 GRAPHIC g103134bgi001.gif GRAPHIC 126421
4 GRAPHIC g103134bgi002.gif GRAPHIC 79462
5 GRAPHIC g103134bgi003.gif GRAPHIC 147911
6 GRAPHIC g103134bgi004.gif GRAPHIC 29002
  Complete submission text file 0001104659-17-020859.txt   595423
Mailing Address 2000 SIERRA POINT PARKWAY SUITE 500 BRISBANE CA 94005
Business Address 2000 SIERRA POINT PARKWAY SUITE 500 BRISBANE CA 94005 6502389600
Innoviva, Inc. (Filer) CIK: 0001080014 (see all company filings)

IRS No.: 943265960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 000-30319 | Film No.: 17732450
SIC: 2834 Pharmaceutical Preparations